Key Takeaways
Biotechnology firm Ribo-B showed significant investor demand in pre-listing trading ahead of its official debut on the Hong Kong Stock Exchange. The strong performance in the grey market, an early indicator of investor sentiment, suggests a positive reception for the upcoming initial public offering (IPO).
- Strong Pre-IPO Pricing: Ribo-B (06938.HK) shares reached a high of 75.4 HKD on the Futu platform, a 30.1% premium over its calculated IPO price of approximately 57.96 HKD.
- High Trading Volume: Combined turnover on the Futu and Phillip Securities platforms exceeded 107 million HKD, signaling robust trading activity and high investor interest before the official listing.
- Bullish Debut Indicator: The substantial price increase and heavy volume in the grey market point to strong bullish sentiment, setting expectations for a potentially powerful opening when the stock begins public trading.
